Health and social responses for methamphetamine users in Europe

Methamphetamine is an established stimulant drug in many parts of the world (e.g. South-east Asia, US), where it has long caused major public health problems. While methamphetamine use in Europe has historically been confined to the Czech Republic and Slovakia, new pockets and patterns of use are now emerging elsewhere in the EU, in diverse populations. In this analysis, EMCDDA looks at challenges for the provision of health and social responses related to this drug today.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.